CHRNA7 and triple-A syndrome: As nicotine is a cholinergic agonist with the potential of targeting the CAP through the activation of α7nAChRs [37], we anticipated that treatment with low-dose nicotine would suppress AAA growth, as shown for other α7nAChRs agonists [22,38].